Literature DB >> 15956780

Diabetes causes inhibition of glucose-6-phosphate dehydrogenase via activation of PKA, which contributes to oxidative stress in rat kidney cortex.

Yizhen Xu1, Brent W Osborne, Robert C Stanton.   

Abstract

The incidence of diabetic nephropathy has been increasing. Studies have shown that oxidative stress (due to increased oxidant production and/or decreased antioxidant activity) is a critical underlying mechanism. The principal intracellular reductant is NADPH whose production is mainly dependent on glucose-6-phosphate dehydrogenase (G6PD) activity. Our work in cultured cells previously showed that high glucose caused activation of protein kinase A (PKA) and subsequent phosphorylation and inhibition of G6PD activity and hence decreased NADPH (Zhang Z, Apse K, Pang J, and Stanton RC. J Biol Chem 275:40042-40047, 2000). The purpose of this study was to determine whether these findings occur in diabetic rats (induced by streptozotocin) compared with control. G6PD activity and accordingly NADPH levels and glutathione levels were significantly decreased in diabetic kidneys compared with control kidneys. Lipid peroxidation was significantly increased, which correlated with decreased G6PD activity (r = 0.48). G6PD expression was significantly reduced, which correlated with decreased G6PD activity (r = 0.72). PKA activity and serine phosphorylation of G6PD were significantly increased and were closely correlated with decreased G6PD activity (r = 0.51 for PKA activity; r = 0.93 for serine phosphorylation of G6PD). Insulin treatment and/or correction of hyperglycemia ameliorated the changes caused by diabetes. In conclusion, chronic hyperglycemia caused inhibition of G6PD activity via decreased expression and increased phosphorylation of G6PD, which therefore led to increased oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956780     DOI: 10.1152/ajprenal.00076.2005

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  64 in total

1.  Regulation of glucose-6-phosphate dehydrogenase by reversible phosphorylation in liver of a freeze tolerant frog.

Authors:  Christopher A Dieni; Kenneth B Storey
Journal:  J Comp Physiol B       Date:  2010-06-10       Impact factor: 2.200

2.  Use of medications to lower urine protein level in patients with diabetic kidney disease.

Authors:  Robert C Stanton
Journal:  Curr Diab Rep       Date:  2010-08       Impact factor: 4.810

3.  Regulation of carbohydrate metabolism by indole-3-carbinol and its metabolite 3,3'-diindolylmethane in high-fat diet-induced C57BL/6J mice.

Authors:  Jayakumar Poornima; Sankaran Mirunalini
Journal:  Mol Cell Biochem       Date:  2013-09-27       Impact factor: 3.396

4.  Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity.

Authors:  Jane A Leopold; Aamir Dam; Bradley A Maron; Anne W Scribner; Ronglih Liao; Diane E Handy; Robert C Stanton; Bertram Pitt; Joseph Loscalzo
Journal:  Nat Med       Date:  2007-02-04       Impact factor: 53.440

5.  Regulation of G6PD acetylation by SIRT2 and KAT9 modulates NADPH homeostasis and cell survival during oxidative stress.

Authors:  Yi-Ping Wang; Li-Sha Zhou; Yu-Zheng Zhao; Shi-Wen Wang; Lei-Lei Chen; Li-Xia Liu; Zhi-Qiang Ling; Fu-Jun Hu; Yi-Ping Sun; Jing-Ye Zhang; Chen Yang; Yi Yang; Yue Xiong; Kun-Liang Guan; Dan Ye
Journal:  EMBO J       Date:  2014-04-25       Impact factor: 11.598

6.  Evaluation of the effect of n-3 PUFA-rich dietary fish oils on lipid profile and membrane fluidity in alloxan-induced diabetic mice (Mus musculus).

Authors:  Shantal Ganapati Kamat; Ramaballav Roy
Journal:  Mol Cell Biochem       Date:  2016-04-21       Impact factor: 3.396

Review 7.  Glucose-6-phosphate dehydrogenase, NADPH, and cell survival.

Authors:  Robert C Stanton
Journal:  IUBMB Life       Date:  2012-03-20       Impact factor: 3.885

8.  Synergistic activation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase by Src kinase elevates superoxide in type 2 diabetic, Zucker fa/fa, rat liver.

Authors:  Rakhee S Gupte; Beverly C Floyd; Mark Kozicky; Shimran George; Zoltan I Ungvari; Vanessa Neito; Michael S Wolin; Sachin A Gupte
Journal:  Free Radic Biol Med       Date:  2009-02-20       Impact factor: 7.376

9.  Attenuation of Armanni-Ebstein lesions in a rat model of diabetes by a new anti-fibrotic, anti-inflammatory agent, FT011.

Authors:  X Lau; Y Zhang; D J Kelly; D I Stapleton
Journal:  Diabetologia       Date:  2012-12-16       Impact factor: 10.122

10.  Stress-induced GSK3 regulates the redox stress response by phosphorylating glucose-6-phosphate dehydrogenase in Arabidopsis.

Authors:  Silvia Dal Santo; Hansjörg Stampfl; Julia Krasensky; Stefan Kempa; Yves Gibon; Elena Petutschnig; Wilfried Rozhon; Alexander Heuck; Tim Clausen; Claudia Jonak
Journal:  Plant Cell       Date:  2012-08-10       Impact factor: 11.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.